Drug recall · June 26, 2013
Actiq (oral transmucosal fentanyl citrate) 200 mcg recall
Why: Failed Dissolution Specification; during stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Actiq (oral transmucosal fentanyl citrate) 200 mcg, lozenge on a stick, a)Single Blister (NDC 63459-502-01), b) 30 count carton (NDC 63459-502-30), Rx only, Manufactured by: Cephalon, Inc., Salt Lake City, UT 84116
- Lots / codes
Lot C88583, exp. 06/15
- Quantity
- 316 cartons
- Company
- Teva Pharmaceuticals USA, Inc., Sellersville, PA
- Distribution
- Product was distributed within the United States to FL, IL, MA, MO, MS, OH and TX. No government or foreign distribution.
- Initiated
- May 28, 2013 · Voluntary: Firm initiated
- Classified
- June 19, 2013
- Reported
- June 26, 2013
- Ended
- July 23, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fentanyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.